Literature DB >> 11115835

Bacteria as the cause of ulcerative colitis.

M Campieri1, P Gionchetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11115835      PMCID： PMC1728175          DOI： 10.1136/gut.48.1.132

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  54 in total

1.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.

Authors:  K L Madsen; J S Doyle; L D Jewell; M M Tavernini; R N Fedorak
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

2.  Ulcerative disease of the colon in laboratory animals induced by pepsin inhibitors.

Authors:  R Marcus; J Watt
Journal:  Gastroenterology       Date:  1974-09       Impact factor: 22.682

3.  Intensive intravenous regimen for severe attacks of ulcerative colitis.

Authors:  S C Truelove; D P Jewell
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

4.  Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.

Authors:  R W Chapman; W S Selby; D P Jewell
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

5.  The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.

Authors:  C Schultsz; F M Van Den Berg; F W Ten Kate; G N Tytgat; J Dankert
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

Review 6.  Intestinal flora in health and disease.

Authors:  G L Simon; S L Gorbach
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

Review 7.  Short chain fatty acids in the human colon.

Authors:  J H Cummings
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

8.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

9.  The colonic epithelium in ulcerative colitis: an energy-deficiency disease?

Authors:  W E Roediger
Journal:  Lancet       Date:  1980-10-04       Impact factor: 79.321

10.  Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis.

Authors:  R J Dickinson; H J O'Connor; I Pinder; I Hamilton; D Johnston; A T Axon
Journal:  Gut       Date:  1985-12       Impact factor: 23.059
View more
  58 in total

1.  The effects from DNA extraction methods on the evaluation of microbial diversity associated with human colonic tissue.

Authors:  Páraic Ó Cuív; Daniel Aguirre de Cárcer; Michelle Jones; Eline S Klaassens; Daniel L Worthley; Vicki L J Whitehall; Seungha Kang; Christopher S McSweeney; Barbara A Leggett; Mark Morrison
Journal:  Microb Ecol       Date:  2010-12-14       Impact factor: 4.552

2.  Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.

Authors:  Ulf Helwig; Karen M Lammers; Fernando Rizzello; Patricia Brigidi; Verena Rohleder; Elisabetta Caramelli; Paolo Gionchetti; Juergen Schrezenmeir; Ulrich R Foelsch; Stefan Schreiber; Massimo Campieri
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

3.  Development of high-throughput phenotyping of metagenomic clones from the human gut microbiome for modulation of eukaryotic cell growth.

Authors:  Karine Gloux; Marion Leclerc; Harout Iliozer; René L'Haridon; Chaysavanh Manichanh; Gérard Corthier; Renaud Nalin; Hervé M Blottière; Joël Doré
Journal:  Appl Environ Microbiol       Date:  2007-03-30       Impact factor: 4.792

4.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

5.  CD4+CD25+ regulatory T cells have divergent effects on intestinal inflammation in IL-10 gene-deficient mice.

Authors:  Beate C Sydora; Sarah M MacFarlane; Michele M Tavernini; Jason S G Doyle; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

6.  Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?

Authors:  Christelle Basset; John Holton; Alexandra Bazeos; Dino Vaira; Stuart Bloom
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation.

Authors:  Yang Xu; Hongxia Dong; Changhui Ge; Yan Gao; Haifeng Liu; Weiguang Li; Chenggang Zhang
Journal:  Ann Transl Med       Date:  2016-08

8.  Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice.

Authors:  Alexander Swidsinski; Vera Loening-Baucke; Herbert Lochs; Laura-P Hale
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

9.  Inhibitory effects of fermented brown rice on induction of acute colitis by dextran sulfate sodium in rats.

Authors:  Keiko Kataoka; Sachiko Ogasa; Tomomi Kuwahara; Yoshimi Bando; Mari Hagiwara; Hideki Arimochi; Shuusuke Nakanishi; Teruaki Iwasaki; Yoshinari Ohnishi
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

10.  Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease.

Authors:  Li Zhang; Si Ming Man; Andrew S Day; Steven T Leach; Daniel A Lemberg; Shoma Dutt; Michael Stormon; Anthony Otley; Edward V O'Loughlin; Annabel Magoffin; Patrick H Y Ng; Hazel Mitchell
Journal:  J Clin Microbiol       Date:  2008-12-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.